RN7SL144P

Across TCGA pan-cancer cohorts, RN7SL144P RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated RN7SL144P data layer.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher RN7SL144P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RN7SL144P expression acts as an unfavorable survival marker, although some lineages such as BRCA and LUAD show a favorable association.

LUSC, KIRC, and LGG are the cancer types where RN7SL144P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	DFS	Quartile	III,IV	0.392	0.721	.002	61	view →
KIRC	DFS	Tertile	IV	0.164	0.438	.004	41	view →
LGG	DFS	Tertile	All	0.757	0.856	<.001	36	view →
UVM	OS	Tertile	All	0.213	0.696	.004	36	view →
THCA	OS	Tertile	III,IV	0.470	0.811	.003	36	view →
HNSC	OS	Tertile	III,IV	0.543	0.656	.014	24	view →
KIRP	OS	Tertile	All	0.513	0.722	.010	19	view →
MESO	DFS	Median	II,III,IV	0.284	0.575	.016	12	view →
BRCA	OS	Tertile	All	0.949	0.916	.026	12	view →
ESCA	OS	Tertile	All	0.371	0.568	.018	9	view →
OV	OS	Median	IV	0.646	0.830	.013	6	view →
LUAD	DFS	Tertile	All	0.785	0.634	.021	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

RN7SL144P–LUSC (DFS)

Open the LUSC breakdown →